In person Molecular glues and targeted protein degraders are changing the landscape of drug discovery. They show great potential for treating diseases such as cancer, infectious, inflammatory, andneurodegenerative diseases, especially for those with “undruggable” pathogenic protein targets. With therecent rise of the ‘molecular glue’ type of protein degraders, new therapies for unmet medical needs are…
16th Winter Conference on Medicinal & Bioorganic Chemistry
In person ZoBio was attending 16th Winter Conference on Medicinal & Bioorganic Chemistry held in the beautiful Steamboat Springs Resort, Colorado. The conference exposed attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery.In addition to the scientific presentations, this meeting provided a…
The Upgrade of X-Ray Crystallography Infrastructure Completed
The availability of 3D structural information plays a vital role in modern drug discovery programs. At ZoBio we deeply understand this and have invested heavily in building a team and a lab to create a powerful X-ray crystallography workflow specifically …
SMR Meeting: Recent Trends in Medicinal Chemistry and Enabling Technologies
In person On 8th December 2022, the Society for Medicines Research and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry were jointly hosting a 1-day meeting in London on Recent Trends in Medicinal Chemistry and Enabling Technologies. The meeting was a combination of medicinal chemistry, chemistry-based drug discovery enabling technologies and…